If you’re looking for a smart stock to buy right now, look no further than Celgene (NASDAQ: CELG). The big biotech has hit a rough patch lately, with a major clinical setback, missing third-quarter revenue expectations, and lowering its full-year 2017 and longer-term outlooks. All this bad news caused some investors to panic and sell off the stock.